Antero Resources heads into early September with a notable divergence taking shape: short sellers are quietly adding exposure while options traders turn the most bullish they've been in months.
The options signal is the sharpest story this week. The put/call ratio has collapsed to 0.67, well below its 20-day average of 1.47 — more than one standard deviation below the mean — marking a dramatic reversal from the heavily defensive positioning that dominated through July and most of August, when the PCR ran above 1.9 for weeks on end. As recently as August 11, the ratio topped 2.03. That kind of sustained hedging has now unwound fast. Call activity is running at its most dominant level of the past year, approaching the 52-week low of 0.36 from the other side. Options traders, in aggregate, are no longer bracing for downside — they're leaning into the rally.
The short interest picture tells a more cautious counter-story. Shorts have been rebuilding steadily. Short interest as a percentage of free float has climbed to 4.6%, up 9% on the week and 34% over the past month — a meaningful acceleration that started around August 10 when shares short were near 10.5 million and have since risen to 14.1 million. Yet the lending market shows no stress at all. Availability is extraordinarily loose at 3,415% — meaning there are more than 34 shares available to borrow for every one already borrowed — and borrowing costs have actually eased over the month to just 0.40%. The short-score reading of 38.4 is unremarkable, ranking in the 39th percentile. This is not a crowded short setup; it looks more like traders adding modest hedges or initiating tactical positions against a strong tape.
The street is leaning bullish, and the analysts have been moving targets higher. Goldman Sachs raised its price target to $48 this week — maintaining its Buy rating — and Raymond James lifted its Strong Buy target to $55, both actions arriving as the stock trades near $39.81, up 5% on the week and 10% over the past month. Wells Fargo and UBS both raised targets after the July earnings print. The mean price target across the consensus sits at $49.95, implying roughly 25% upside from here. Barclays remains the lone sceptic in recent moves, nudging its Equal-Weight target down fractionally to $45 in mid-August. On valuation, the trailing PE has expanded to 8.9x and EV/EBITDA runs at 5.4x — neither stretched, with the 30-day moves in book value and earnings yield modest. Peer RRC added 3.4% on the week, EQT gained 2.9%, and CRK surged 13% — Antero's 4.9% weekly gain keeps it roughly in line with the Appalachian pack, with CRK a notable outlier to the upside.
On ownership, institutional holders continue to build. BlackRock added nearly 500,000 shares to reach 8.95% of outstanding shares. Dimensional Fund Advisors put on 2.46 million shares in the most recent reporting period, and Invesco added 2.84 million. FMR's activist filing in August shows their stake trimmed from 8.2% to 5.4% — still above the 5% disclosure threshold — though the filing is passive and carries no activist intent. Insider data is stale (last material trade in January), so no fresh signal there.
The next catalyst is Q3 results, scheduled for October 28. After the most recent print delivered a 4.2% single-day move and analysts moved targets higher across the board, the question heading toward that date will be whether the options market's sudden confidence is vindicated by production data — or whether the rebuilding short base turns out to have the better read.
See the live data behind this article on ORTEX.
Open AR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
